These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 17374366

  • 21. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
    Bresalier RS, Byrd JC, Wang L, Raz A.
    Cancer Res; 1996 Oct 01; 56(19):4354-7. PubMed ID: 8813123
    [Abstract] [Full Text] [Related]

  • 22. Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate.
    Iacomino G, Tecce MF, Grimaldi C, Tosto M, Russo GL.
    Biochem Biophys Res Commun; 2001 Aug 03; 285(5):1280-9. PubMed ID: 11478796
    [Abstract] [Full Text] [Related]

  • 23. Leukotriene D4 upregulates MUC2 gene transcription in human epithelial cells.
    Suzuki S, Takeuchi K, Ishinaga H, Basbaum C, Majima Y.
    Pharmacology; 2008 Aug 03; 81(3):221-8. PubMed ID: 18176092
    [Abstract] [Full Text] [Related]

  • 24. HDAC3 overexpression and colon cancer cell proliferation and differentiation.
    Spurling CC, Godman CA, Noonan EJ, Rasmussen TP, Rosenberg DW, Giardina C.
    Mol Carcinog; 2008 Feb 03; 47(2):137-47. PubMed ID: 17849419
    [Abstract] [Full Text] [Related]

  • 25. RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
    Bessard A, Frémin C, Ezan F, Fautrel A, Gailhouste L, Baffet G.
    Oncogene; 2008 Sep 11; 27(40):5315-25. PubMed ID: 18521085
    [Abstract] [Full Text] [Related]

  • 26. Effect of serum in the growth medium on mucin synthesis by colon cancer cell line.
    Niv Y, Kim YS.
    Isr J Med Sci; 1995 Oct 11; 31(10):600-3. PubMed ID: 7591682
    [Abstract] [Full Text] [Related]

  • 27. In vitro models for the study of the effect of butyrate on human colon adenocarcinoma cells.
    Olmo N, Turnay J, Pérez-Ramos P, Lecona E, Barrasa JI, López de Silanes I, Lizarbe MA.
    Toxicol In Vitro; 2007 Mar 11; 21(2):262-70. PubMed ID: 17084582
    [Abstract] [Full Text] [Related]

  • 28. A role for Hath1, a bHLH transcription factor, in colon adenocarcinoma.
    Leow CC, Polakis P, Gao WQ.
    Ann N Y Acad Sci; 2005 Nov 11; 1059():174-83. PubMed ID: 16382053
    [Abstract] [Full Text] [Related]

  • 29. Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.
    Choudry HA, Mavanur A, O'Malley ME, Zeh HJ, Guo Z, Bartlett DL.
    Ann Surg Oncol; 2012 May 11; 19(5):1402-9. PubMed ID: 22302271
    [Abstract] [Full Text] [Related]

  • 30. Human fetal colon cells and colon cancer cells respond differently to butyrate and PUFAs.
    Hofmanová J, Vaculová A, Koubková Z, Hýzd'alová M, Kozubík A.
    Mol Nutr Food Res; 2009 May 11; 53 Suppl 1():S102-13. PubMed ID: 19156717
    [Abstract] [Full Text] [Related]

  • 31. Calretinin and calretinin-22k increase resistance toward sodium butyrate-induced differentiation in CaCo-2 colon adenocarcinoma cells.
    Marilley D, Vonlanthen S, Gioria A, Schwaller B.
    Exp Cell Res; 2001 Aug 01; 268(1):93-103. PubMed ID: 11461122
    [Abstract] [Full Text] [Related]

  • 32. Terrein inhibits keratinocyte proliferation via ERK inactivation and G2/M cell cycle arrest.
    Kim DS, Lee HK, Park SH, Lee S, Ryoo IJ, Kim WG, Yoo ID, Na JI, Kwon SB, Park KC.
    Exp Dermatol; 2008 Apr 01; 17(4):312-7. PubMed ID: 17979972
    [Abstract] [Full Text] [Related]

  • 33. Intestinal MUC2 and gastric M1/MUC5AC in preneoplastic lesions induced by 1,2-dimethylhydrazine in rat: a sequential analysis.
    Zoghbi S, Drouin E, Claustre J, Bara J, Scoazec JY, Plaisancié P.
    Int J Oncol; 2007 Feb 01; 30(2):489-97. PubMed ID: 17203232
    [Abstract] [Full Text] [Related]

  • 34. Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex.
    Blouin JM, Penot G, Collinet M, Nacfer M, Forest C, Laurent-Puig P, Coumoul X, Barouki R, Benelli C, Bortoli S.
    Int J Cancer; 2011 Jun 01; 128(11):2591-601. PubMed ID: 20715114
    [Abstract] [Full Text] [Related]

  • 35. A proteomic analysis of differential cellular responses to the short-chain fatty acids butyrate, valerate and propionate in colon epithelial cancer cells.
    Kilner J, Waby JS, Chowdry J, Khan AQ, Noirel J, Wright PC, Corfe BM, Evans CA.
    Mol Biosyst; 2012 Apr 01; 8(4):1146-56. PubMed ID: 22075547
    [Abstract] [Full Text] [Related]

  • 36. Butyrate-stimulated H2S production in colon cancer cells.
    Cao Q, Zhang L, Yang G, Xu C, Wang R.
    Antioxid Redox Signal; 2010 May 01; 12(9):1101-9. PubMed ID: 19803745
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
    Ma G, Tabanca N, Husnu Can Baser K, Kirimer N, Pasco DS, Khan IA, Khan SI.
    Cancer Chemother Pharmacol; 2009 Mar 01; 63(4):673-80. PubMed ID: 18597088
    [Abstract] [Full Text] [Related]

  • 38. Ascorbic acid 6-palmitate suppresses gap-junctional intercellular communication through phosphorylation of connexin 43 via activation of the MEK-ERK pathway.
    Lee KM, Kwon JY, Lee KW, Lee HJ.
    Mutat Res; 2009 Jan 15; 660(1-2):51-6. PubMed ID: 19026667
    [Abstract] [Full Text] [Related]

  • 39. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.
    Hogan FS, Krishnegowda NK, Mikhailova M, Kahlenberg MS.
    J Surg Res; 2007 Nov 15; 143(1):58-65. PubMed ID: 17950073
    [Abstract] [Full Text] [Related]

  • 40. Sensitization of colon cancer cell lines to butyrate-mediated proliferation inhibition by combined application of indomethacin and nordihydroguaiaretic acid.
    Galfi P, Neogrady Z, Amberger A, Margreiter R, Csordas A.
    Cancer Detect Prev; 2005 Nov 15; 29(3):276-85. PubMed ID: 15936596
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.